// App-Quantinova.ai

425 : Molecular profiling of advanced pancreatic ductal adenocarcinoma (PDAC): Role of ctDNA.

Researchers

Presenter

  • Angela Lamarca

Principal Investigators

  • Mairead Geraldine McNamara

  • Richard Hubner

  • Juan W. Valle

Medical Centers

  • Department of Medical Oncology, The Christie NHS Foundation Trust / Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • University of Manchester, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom

Locations

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Transcription factor Maf

  • Circulating DNA

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A